Nxu Inc., a Delaware corporation listed on NASDAQ under the symbol NXU, has filed a Current Report on Form 8-K with the United States Securities and Exchange Commission (SEC) on November 19, 2024. The report announces the commencement of a merger process involving Nxu Inc., its wholly owned subsidiaries Nxu Merger Sub, Inc. and Nxu Merger Sub, LLC, and Verde Bioresins, Inc. According to the Merger Agreement, Nxu Merger Sub, Inc. will first merge with Verde, with Verde continuing as a wholly owned subsidiary of Nxu. This will be followed by Verde's merger with Nxu Merger Sub, LLC, with the latter surviving the merger. Nxu has also made available an Investor Presentation to provide details about the proposed merger to investors...Show More

Nxu Inc., a Delaware corporation listed on NASDAQ under the symbol NXU, has filed a Current Report on Form 8-K with the United States Securities and Exchange Commission (SEC) on November 19, 2024. The report announces the commencement of a merger process involving Nxu Inc., its wholly owned subsidiaries Nxu Merger Sub, Inc. and Nxu Merger Sub, LLC, and Verde Bioresins, Inc. According to the Merger Agreement, Nxu Merger Sub, Inc. will first merge with Verde, with Verde continuing as a wholly owned subsidiary of Nxu. This will be followed by Verde's merger with Nxu Merger Sub, LLC, with the latter surviving the merger. Nxu has also made available an Investor Presentation to provide details about the proposed merger to investors. The presentation is included as Exhibit 99.1 in the report. The report contains forward-looking statements regarding the merger, including the expected benefits, timing, and completion of the merger, subject to the satisfaction of closing conditions and regulatory approvals. Nxu's management, including CEO Mark Hanchett, may be considered participants in the solicitation of proxies in connection with the proposed transaction. The report emphasizes that the information provided is not to be considered as filed under the Exchange Act nor incorporated by reference into any filing under the Securities Act, except as explicitly stated in such filings.